Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging in Endoscopic Spinal Surgery
NCT05808140Phase 2Completed
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Apr 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of indocyanine green in lumbar disc herniation (LDH) (4 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Fluorescence imaging rate of nerve roots, Fluorescence signal ratio of nerve root to back fluorescence and 1 more. Started Apr 2023; status: completed.
02
Drugs
indocyanine green
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT05808140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05808140.